Millennium Management
KZR

Millennium Management’s Kezar Life Sciences KZR Stock Holding History

Millennium Management’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-9,000
Closed -$775K – 6816
2022
Q3 		$775K Sell
9,000
-23,240
-72% -$2.26M ﹤0.01% 4557
2022
Q2 		$2.67M Buy
32,240
+27,240
+545% +$2.4M ﹤0.01% 3409
2022
Q1 		$831K Buy
+5,000
New +$718K ﹤0.01% 4708

Other funds holding KZR

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RC
Rangeley Capital New Canaan, Connecticut $103M AUM 77.32% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Millennium Management's KZR Position: Q1 2026 in Review

Millennium Management opened a new position in Kezar Life Sciences (KZR) in Q1 2026: 142,050 shares worth $1.05M. The stake represents ﹤0.01% of the portfolio and ranks #4354 among its holdings. This is a return to the name: Millennium Management previously reported a position in KZR as recently as Q2 2025.

Millennium Management first reported a position in KZR in Q2 2018 and has held it in 28 quarters since. The position peaked at $25.5M in Q3 2022. 43 funds tracked by Wall St. Rank hold KZR as of Q1 2026.

  • Millennium Management held 142,050 shares of Kezar Life Sciences worth $1.05M as of Q1 2026.
  • Kezar Life Sciences was a new Millennium Management position in Q1 2026.
  • Kezar Life Sciences made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #4354 holding.
  • Millennium Management first reported a position in Kezar Life Sciences in Q2 2018 and has held it in 28 quarters since.
  • Millennium Management's Kezar Life Sciences position peaked at $25.5M in Q3 2022.
  • 43 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.